The report of global osteoarthritis drugs market by Drug Class (NSAIDs, Opioids, Viscosupplements, and Corticosteroids) Route of Administration (Oral, Parenteral, and Topical) Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Dosage Form (Solid, Liquid, and Semi-solid) and Region (Asia Pacific, North America, Europe, Latin America, and Middle East Africa) is expected to reach US$ 10316.79 Mn by 2026, at a CAGR of XX% during a forecast period.
Osteoarthritis (OA) is known as degenerative joint disease or degenerative arthritis is among the common chronic conditions of the joint. OA can affect any joint in the knees, hips, lower back, and neck. When an individual suffers from OA, the cartilage that provides a smooth, gliding surface for joint motion breaks down, causing pain, swelling, and other issues in the movement of the joints in the body. Osteoarthritis pain drugs are used to relief the pain that occurs when a person suffers from OA. A strong pipeline portfolio coupled with the increasing prevalence of OA are mainly drive the market globally. According to World Health Organization, osteoarthritis is one of the ten most disabling diseases in urbanized countries. However, loss of patent exclusivity of branded therapies, the side effects of the drugs, more awareness and promising drugs that may hamper the market growth at global level.
NSAIDs segment is expected to grow at the highest XX% CAGR during the forecast period.
The non-steroidal anti-inflammatory drugs (NSAIDs) is expected to hold at the largest market share during the forecast period. They are found to be the most commonly used drugs to ease pain, inflammation, and stiffness that come with arthritis, bursitis, and tendinitis. Therefore, NSAIDs have been an important drugs for the symptoms of osteoarthritis for a very long time. They are also cheap and often among the first medicines prescribed for people with achy joints.
The North America dominated the global osteoarthritis drugs market in 2018
North America held the largest market share in 2018wth and is expected to continue the same trend over the forecast period, owing to the increasing lifestyle changes, an increasing number of obesity cases, and an extensive rise in the geriatric population in North America, the adoption of treatment and drugs is also increasing in the region. The availability of better treatment options, high awareness among people, government reimbursement policies, and the willingness to take up treatment are expected to expand to the growth of the osteoarthritis drug market in the region.
Key players operating the global osteoarthritis drugs market are Bayer Healthcare, Lifecore Biomedical LLC, Merck Serono, Pfizer Consumer Healthcare, Iroko Pharmaceuticals, Sanofi SA, Smith & Nephew PLC, Zimmer Biome, Abbott Laboratorie, Johnson & Johnson, Novartis A, Pfizer Inc., AbbVie Inc., Eli Lilly and Compan, ABIOGEN PHARMA S.p., Horizon Pharma plc, Ferring B.V, Merck Sharp & Dohme Corp, Medivir, Bioventus, Inc., Flexion Therapeutics, Inc., Regeneron, GlaxoSmithKline Plc.
Maximize Market Research, a global market research firm with a dedicated team of specialists and data has carried out extensive research about the global osteoarthritis drugs market. The report encompasses the market by different segments and region, providing an in-depth analysis of the overall industry ecosystem, useful for making an informed strategic decision by the key stakeholders in the industry. Importantly, the report delivers forecasts and share of the market, further giving an insight into the market dynamics, and future opportunities that might exist in the global osteoarthritis drugs market. The driving forces, as well as considerable restraints, have been explained in depth. in addition to this, competitive landscape describing the strategic growth of the competitors have been taken into consideration for enhancing market know-how of our clients and at the same time explain global osteoarthritis drugs market positioning of competitors.
Browse the market data Tables and Figures spread through a comprehensive research report and in-depth TOC on “Global Osteoarthritis Drugs Market”
https://www.maximizemarketresearch.com/market-report/global-osteoarthritis-drugs-market/36280/
Contact:
MAXIMIZE MARKET RESEARCH PVT. LTD.
Omkar Heights,
ManikBaug, Vadgaon Bk,
Sinhagad Road, Pune – 411051, Maharashtra, India.
+91 9607195908